The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
Characteristics of neurotoxicity associated with idecabtagene vicleucel (ide-cel, bb2121) in patients with relapsed and refractory multiple myeloma (RRMM) in the pivotal phase II KarMMa study.
 
Salomon Manier
Consulting or Advisory Role - Amgen (Inst); Celgene (Inst); Janssen Oncology (Inst)
Research Funding - Celgene (Inst); Janssen Oncology (Inst)
 
Ankit J. Kansagra
Consulting or Advisory Role - Alnylam; Celgene; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Oncopeptides; Pfizer; Pharmacyclics; Sanofi; Takeda
 
Larry D. Anderson, Jr
Honoraria - Amgen; celgene; GlaxoSmithKline; janssen; Karyopharm Therapeutics; Oncopeptides
Consulting or Advisory Role - amgen; bms; celgene; GlaxoSmithKline; janssen; Karyopharm Therapeutics; Oncopeptides
Speakers' Bureau - amgen; celgene; Takeda
Research Funding - amgen; bms; celgene; GlaxoSmithKline; janssen; Karyopharm Therapeutics
 
Jesus G. Berdeja
Consulting or Advisory Role - Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); crispr therapeutics (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Kite, a Gilead company (Inst); Legend Biotech (Inst); Secura Bio (Inst); SERVIER (Inst); Takeda (Inst)
Research Funding - Abbvie (Inst); Acetylon Pharmaceuticals (Inst); Amgen (Inst); Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celularity (Inst); Constellation Pharmaceuticals (Inst); crispr therapeutics (Inst); CURIS (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Glenmark (Inst); Ichnos Sciences (Inst); Janssen (Inst); Kesios Therapuetics (Inst); Lilly (Inst); Novartis (Inst); poseida therapeutics (Inst); Sanofi (Inst); Takeda (Inst); Teva (Inst); Vivolux (Inst)
 
Sundar Jagannath
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen; Karyopharm Therapeutics; Legend Biotech; Sanofi; Takeda
 
Yi Lin
Consulting or Advisory Role - Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Gamida Cell (Inst); Janssen Oncology (Inst); Juno Therapeutics (Inst); Kite/Gilead (Inst); Legend Biotech (Inst); Novartis (Inst); Sorrento Therapeutics (Inst); Vineti (Inst)
Research Funding - Bluebird Bio (Inst); Boston Scientific (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Janssen Oncology (Inst); Kite/Gilead (Inst); Merck (Inst); Takeda (Inst)
 
Sagar Lonial
Stock and Other Ownership Interests - TG Therapeutics
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Merck; Novartis; Sanofi; Takeda
Research Funding - Bristol-Myers Squibb; Celgene; Takeda
Other Relationship - TG Therapeutics
 
Nina Shah
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech/Abbvie; Indapta Therapeutics; Karyopharm Therapeutics; Oncopeptides; Precision Biosciences; Sanofi; Surface Oncology
Research Funding - Bluebird Bio; Celgene; Janssen; Nektar; poseida therapeutics; Sutro biopharma; Teneobio
 
Noopur S. Raje
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen Oncology; Merck; Novartis; Takeda
Research Funding - Bluebird Bio (Inst)
 
David Samuel DiCapua Siegel
Honoraria - Amgen; Bristol-Myers Squibb; Celularity; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Merck; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celularity; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Merck; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Merck; Takeda
Research Funding - Amgen; Bristol-Myers Squibb; Celularity; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Merck; Takeda
 
Albert Oriol
Consulting or Advisory Role - Amgen; Celgene; GlaxoSmithKline; Janssen; Sanofi
Speakers' Bureau - Amgen; Celgene
 
Anna Truppel-Hartmann
Employment - Bluebird Bio
Stock and Other Ownership Interests - Bristol-Myers Squibb; F. Hoffmann LaRoche
Travel, Accommodations, Expenses - Bluebird Bio
 
Everton Rowe
Employment - Bristol-Myers Squibb
 
Payal Patel
Employment - Bristol-Myers Squibb
 
Amit Agarwal
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Timothy B. Campbell
No Relationships to Disclose
 
Paula Rodríguez-Otero
Honoraria - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen; Kite, a Gilead company; Oncopeptides; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen; Kite, a Gilead company; Oncopeptides; Sanofi; Takeda
 
Nikhil C. Munshi
Stock and Other Ownership Interests - OncoPep
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; Amgen; BeiGene; Bristol-Myers Squibb; Celgene; Janssen; Karyopharm Therapeutics; Karyopharm Therapeutics; OncoPep; Takeda
Patents, Royalties, Other Intellectual Property - Oncopep